Labopharm seeking FDA dispute resolution

Labopharm says it is seeking formal FDA dispute resolution proceedings to counter an approvable letter from the agency requiring undisclosed additional work on its NDA for a once-daily formulation of the pain-reliever tramadol.

You must be a registered member of MMM to post a comment.

Next Article in Legal/Regulatory